Surgery in esophageal cancer: a Phase 2 trial joins PharmaTerminal's active board
Published 10/15/2026 · By Curebiology
PharmaTerminal's Active Clinical Trials board this week puts a Phase 2 study of surgery in esophageal cancer near the top of its list, recorded on ClinicalTrials.gov as NCT07162506. The trial is listed as recruiting, with an enrollment of 120 and an estimated completion date in 2030. It is notable this week because it sits at position 2 of the 15 trials the terminal is currently tracking, on a board the app orders by ClinicalTrials.gov last-update date.
What is being studied
The intervention recorded on the registry is Surgery, and the condition under study is esophageal cancer. That makes this a procedural entry rather than a drug entry: the record names an operation, not a compound, so it is described here exactly as the registry describes it. The record lists the study as Phase 2. Its status field reads RECRUITING, and the enrollment figure entered on the record is 120. The sponsor field is recorded as Unknown, so the registry entry does not name a sponsor at this stage.
Stage and recorded endpoint
The primary endpoint, as recorded, is DFS. The registry also lists an estimated completion date of 2030-08-30, which places the study on a longer horizon than several other entries on the board. These are registry values as entered by the study's record; the post does not reinterpret them into outcomes, and no results are reported here.
Where to track this
PharmaTerminal carries this record, and the rest of its active-trials board, at https://pharmaterminal.aeah.ai/#/dashboard. The item appears in the Active Clinical Trials (dashboard) section, which is where the terminal presents live Phase 2 and Phase 3 trials, its pipeline tracker and approvals in one place. Opening the dashboard at https://pharmaterminal.aeah.ai/#/dashboard lets readers follow the study's status and endpoint alongside the other trials ranked around it.
Source
Upstream record: ClinicalTrials.gov, https://clinicaltrials.gov/study/NCT07162506. The same record is presented in PharmaTerminal at https://pharmaterminal.aeah.ai/#/dashboard.
This is a summary of public registry and aggregated data and is not medical or investment advice.